These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 25787955)

  • 81. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
    Morelli E; Moore H; Rebello TJ; Gray N; Steele K; Esposito E; Gingrich JA; Ansorge MS
    J Neurosci; 2011 Nov; 31(44):15742-50. PubMed ID: 22049417
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Chronic fluoxetine rescues changes in plasma membrane density of 5-HT1A autoreceptors and serotonin transporters in the olfactory bulbectomy rodent model of depression.
    Riad M; Kobert A; Descarries L; Boye S; Rompré PP; Lacaille JC
    Neuroscience; 2017 Jul; 356():78-88. PubMed ID: 28528967
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A; Millan MJ
    Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
    Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
    Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Reduced 5-HT1A- and GABAB receptor function in dorsal raphé neurons upon chronic fluoxetine treatment of socially stressed rats.
    Cornelisse LN; Van der Harst JE; Lodder JC; Baarendse PJ; Timmerman AJ; Mansvelder HD; Spruijt BM; Brussaard AB
    J Neurophysiol; 2007 Jul; 98(1):196-204. PubMed ID: 17460100
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Activity-dependent presynaptic effect of serotonin 1B receptors on the somatosensory thalamocortical transmission in neonatal mice.
    Laurent A; Goaillard JM; Cases O; Lebrand C; Gaspar P; Ropert N
    J Neurosci; 2002 Feb; 22(3):886-900. PubMed ID: 11826118
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
    Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
    J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W; Ding S; Zhou FM
    J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Preferential Modulatory Action of 5-HT
    Guilhemsang L; Gutierrez-Ceballos A; Antonazzo M; Mallet NP; Ugedo L; Morera-Herreras T
    J Neurosci; 2023 Jan; 43(1):56-67. PubMed ID: 36400530
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Bidirectional plasticity in striatonigral synapses: a switch to balance direct and indirect basal ganglia pathways.
    Aceves JJ; Rueda-Orozco PE; Hernandez-Martinez R; Galarraga E; Bargas J
    Learn Mem; 2011 Dec; 18(12):764-73. PubMed ID: 22101179
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses.
    Dorostkar MM; Boehm S
    J Neurochem; 2007 Jan; 100(2):395-405. PubMed ID: 17064350
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca²⁺ dependent manner.
    Avalos-Fuentes A; Loya-López S; Flores-Pérez A; Recillas-Morales S; Cortés H; Paz-Bermúdez F; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2013 Aug; 71():273-81. PubMed ID: 23602989
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Homozygote mice deficient in serotonin 5-HT1B receptor and antidepressant effect of selective serotonin reuptake inhibitors].
    Trillat AC; Malagié I; Bourin M; Jacquot C; Hen R; Gardier AM
    C R Seances Soc Biol Fil; 1998; 192(6):1139-47. PubMed ID: 10101609
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Optostimulation of striatonigral terminals in substantia nigra induces dyskinesia that increases after L-DOPA in a mouse model of Parkinson's disease.
    Keifman E; Ruiz-DeDiego I; Pafundo DE; Paz RM; Solís O; Murer MG; Moratalla R
    Br J Pharmacol; 2019 Jul; 176(13):2146-2161. PubMed ID: 30895594
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 98. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
    Eriksson TM; Holst S; Stan TL; Hager T; Sjögren B; Ogren SÖ; Svenningsson P; Stiedl O
    Neuropharmacology; 2012 Nov; 63(6):1150-60. PubMed ID: 22801295
    [TBL] [Abstract][Full Text] [Related]  

  • 99. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.